ACAD
Acadia Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.15 / 10Overall Score
NeturalInvestment Rating
4.15 / 10Overall Score
NeturalInvestment Rating
Should I Buy ACAD Now?
- Based on a composite score of 4.15/10, we rate ACAD as a Netural. Our analysis breaks down into 2.97/10 for Fundamentals, 4.58/10 for Technicals, and 4.53/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for ACAD?
Is ACAD fundamentally strong?
What is the market sentiment for ACAD?
Should I Buy ACAD Now?
- Based on a composite score of 4.15/10, we rate ACAD as a Netural. Our analysis breaks down into 2.97/10 for Fundamentals, 4.58/10 for Technicals, and 4.53/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ACAD fundamentally strong?
What is the current technical signals for ACAD?
What is the market sentiment for ACAD?
